A Multicenter Prospective Non-Interventional Study Assessing the Management of Canadian Women With Uterine Fibroids
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02580578|
Recruitment Status : Completed
First Posted : October 20, 2015
Last Update Posted : February 28, 2020
|Condition or disease||Intervention/treatment|
|Leiomyoma||Other: No Intervention|
|Study Type :||Observational|
|Actual Enrollment :||1500 participants|
|Official Title:||A Multicentre Prospective Non-interventional Study Assessing the Management of Canadian Women With Uterine Fibroids, a Patient Registry|
|Actual Study Start Date :||July 31, 2015|
|Actual Primary Completion Date :||January 31, 2020|
|Actual Study Completion Date :||January 31, 2020|
Female patients who are diagnosed and treated for symptoms associated with their uterine fibroids per routine clinical practice. No intervention is administered in this study.
Other: No Intervention
No intervention is administered in this study.
- Uterine Fibroid Symptom Quality of Life 37-Item Questionnaire (UFS QoL) [ Time Frame: 24 Months ]
- Ruta Menorrhagia (Bleeding) 15-Item Questionnaire [ Time Frame: 24 Months ]
- Number of Participants with Adverse Drug Reactions [ Time Frame: 24 Months ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02580578
|Study Director:||Carmen Enciu||Allergan|